日本の近赤外線イメージング市場の評価：製品・用途・エンドユーザー・地域別の機会および予測 (2018-2032年)

日本の近赤外線イメージングの市場規模は、2024年の1億1,609万米ドルから、予測期間中はCAGR 5.64%で推移し、2032年には1億8,006万米ドルに成長すると予測されています。日本の近赤外線イメージング市場は、癌、心血管疾患、神経疾患などの慢性疾患の有病率の上昇と、高度なイメージング技術に対する需要の増加により、予測期間中に堅調な成長が見込まれています。

近赤外イメージングとは、近赤外光を用いて組織や物体内部の構造的機能や活動を見る、目に見えないイメージング技術です。高度なイメージングソリューションは診断や治療の成果を向上させることができます。AIや高度な蛍光剤の追加などの技術開発により、可視化システムの性能は赤外線でほぼ改善され、さまざまなヘルスケア用途への実装が行われています。さらに、特に腫瘍や再建術などの低侵襲手術や画像誘導手術におけるNIRイメージングの利用が増加していることが、市場成長の原動力となっています。例えば、2024年3月、Artience Co., Ltd.は、細胞やエクソソームの高感度イメージング用の先進的な近赤外蛍光プローブ、Sciforiem FIシリーズを発表しました。これらのプローブは、高速で鮮明な染色、高い蛍光強度、優れた光安定性を提供します。

当レポートでは、日本の近赤外線イメージングの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分別の詳細分析、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 日本の近赤外線イメージング市場の展望

• 市場規模の分析・予測
• 市場シェアの分析・予測
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 企業シェア分析（上位5社およびその他）
• 市場マップ分析

第5章 需給分析

第6章 バリューチェーン分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

• 市場促進要因
• 市場の課題

第11章 市場動向・展開

第12章 規制枠組みとイノベーション

• 規制当局の承認
• イノベーション

第13章 特許の情勢

第14章 ケーススタディ

第15章 競合情勢

• 上位5社の競合マトリックス
• 上位5社のSWOT分析
• 上位10社の情勢
  • Carl Zeiss Meditec AG
  • Shimadzu Corporation
  • Stryker Corporation.
  • Olympus Corporation.
  • Hamamatsu Photonics K.K.
  • Medtronic plc

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Near-Infrared Imaging Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Near-Infrared Imaging Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Near-Infrared Imaging Market Share (%), By Application, FY2018-FY2032F
• Figure 4. Japan Near-Infrared Imaging Market Share (%), By End-user, FY2018-FY2032F
• Figure 5. Japan Near-Infrared Imaging Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 7. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

Japan near-infrared imaging (NIR) market is projected to witness a CAGR of 5.64% during the forecast period FY2025-FY2032, growing from USD 116.09 million in FY2024 to USD 180.06 million in FY2032. The near-infrared imaging market in Japan is expected to grow robustly during the forecast period owing to the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, and increased demand for advanced imaging technologies.

Near-infrared imaging is an invisible imaging technique that uses near-infrared light to view the structural function and activity inside the tissue or objects. Moreover, advanced imaging solutions can improve diagnostic and treatment outcomes. With technological developments such as artificial intelligence and the addition of advanced fluorescent agents, the performance of the visualization system is almost improved in infrared form, and implementation in various healthcare applications is supplied. Additionally, the increased utilization of NIR imaging in minimally invasive and image-guided surgeries, especially in oncology and reconstructive procedures, is driving market growth. For instance, in March 2024, Artience Co., Ltd. announced the Sciforiem FI Series, advanced near-infrared fluorescence probes, for high-sensitivity imaging of cells and exosomes. These probes offer fast, vivid staining, high fluorescence intensity, and superior photostability.

Rising Demand for Non-Invasive Diagnostics for Chronic and Age-Related Diseases

The growing demand for non-invasive diagnostic solutions for treating chronic and age-related diseases is a key driver for the growth of the near-infrared imaging market in Japan. Japan's aging population leads to an increase in the prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders, thereby increasing the need for advanced imaging technologies that provide accurate real-time information without the risks associated with invasive procedures. NIR imaging's ability to visualize biological tissues safely, painlessly, and in detail makes it an attractive option for early diagnosis and monitoring, facilitating easy implementation in clinical and research settings. This trend is expected to continue to drive market expansion as healthcare providers favor patient-centric, minimally invasive diagnostic approaches. For instance, a study published in the Anticancer Research Journal evaluated the feasibility of combining near-infrared photoimmunotherapy with immune checkpoint inhibitor therapy for unresectable recurrent head and neck cancer. Conducted at Ryukyu University Hospital, the study included five patients, four of whom received NIR-PIT combined with pembrolizumab. A 100% best-observed response rate was achieved among seven treated lesions, with three complete and four partial responses.

Advancements in Imaging Technologies Drive Market Growth

Advances in imaging technologies are major growth drivers for the Japan near-infrared imaging market. Incorporating cutting-edge innovations such as artificial intelligence, improved fluorescence agents, and high-resolution sensors greatly enhanced NIR imaging systems' accuracy, sensitivity, and real-time capabilities. Technological advances allow for more accurate diagnostics, especially in complex medical applications such as oncology, neurology, and cardiovascular imaging. Portable and low-cost solutions for NIR imaging are bringing the market within the reach of different settings, including hospitals and point-of-care facilities. Therefore, the prospects of this technology further improve the demands for NIR imaging as the advancement in imaging technology progresses. For instance, in October 2024, e-con Systems Inc. launched the See3CAM_CU83, a 4K RGB-IR superspeed USB camera featuring onsemi's AR0830 sensor. This innovative camera captures both RGB and infrared images simultaneously, making it suitable for various applications such as biometric access control, in-cabin monitoring, crop health monitoring, image-guided surgeries, and smart patient monitoring.

Near-Infrared Devices Segment to Dominate the Near-Infrared Imaging Market

The near-infrared devices segment is expected to capture the maximum market share in the near-infrared imaging market, led by extensive use across sectors such as health care, manufacturing, and agriculture, which can make this possible. It is encompassed by cameras, sensors, and even systems with high-quality capabilities in real-time analysis, non-invasive diagnostics, and material inspection. Its applications in health care are highly in demand nowadays as a better diagnostic tool for chronic diseases and surgical guidance. Meanwhile, industries use NIR devices for quality control and defect control. Ongoing technological advancements in this segment, including improved sensitivity and portability, are expected to maintain market leadership and will continue contributing to market growth. For instance, in August 2024, Shimadzu Corporation launched the LuminousQuester NI, a near-infrared imaging system designed to enhance drug discovery research. This system features a camera that simultaneously captures near-infrared and visible light and dedicated software for nonclinical applications.

Preclinical Imaging Segment to Dominate the Near-Infrared Imaging Market

The preclinical imaging segment is expected to dominate the Japan near-infrared imaging market, with rising demand for advanced imaging solutions primarily in drug discovery, disease modeling, and preclinical research expected to drive market growth. Near-infrared imaging is a high-resolution, non-invasive, real-time technique for visualizing biological processes. As such, they play an important role in early-stage research for evaluating treatment efficacy and monitoring disease progression. Their high sensitivity and specificity in tracking molecular and cellular activity enhance their utility in preclinical research, especially in the areas of oncology, neurology, and cardiovascular research. The demand for efficient and accurate preclinical imaging technologies, especially with pharmaceutical and biotechnology companies continuing to focus on developing novel therapeutics, will propel significant growth in this segment. For instance, in October 2021, MILabs B.V. introduced its 7 Series Integrated Line of products, enhancing user experience by improving the performance of individual imaging modalities and their integration. The new system reveals molecular images previously obscured by noise, enabling advanced applications such as SPECT to PET translation, fluorescence and bioluminescence tomography, and targeted radiotherapy with high-energy tracers.

Future Market Scenario (FY2025-FY2032F)

Continuous innovations in miniaturized, high-resolution NIR imaging systems will push the adoption of these applications into medical, industrial, and scientific use.

Growing usage in healthcare, food inspection, environmental monitoring, and semiconductor testing is going to open up wider markets.

The demand for NIR imaging in medical applications like tissue imaging and surgical guidance is increasing due to the increased needs of healthcare, which are driven by the aging population and by a focus on precision diagnostics.

Strong governmental support and investments in research and development are fostering innovation and market growth.

The market is going to be more competitive in nature, where the focus will be on product differentiation, customization, and localized solutions to meet industry-specific demands.

Key Players Landscape and Outlook

Japan near-infrared imaging market is shaped by strategic initiatives such as mergers, acquisitions, and collaborations among key players, driving innovation and growth. Regulatory approvals for new products further enhance market expansion, positioning NIR imaging for continued development and increased adoption across various sectors.

For instance, in February 2024, Hamamatsu Photonics K.K. introduced the C16741-40U, a high-performance InGaAs camera with sensitivity from 400 nm to 1700 nm, spanning visible to SWIR regions. Due to minimized readout noise, it delivers high-resolution imaging with an exceptional signal-to-noise ratio. Integrated Peltier cooling ensures sensor stability, while the USB 3.1 Gen 1 interface supports 12-bit imaging and adjustable exposure times. Designed for food sorting, plastic recycling, silicon wafer inspection, laser alignment, and solar cell evaluation.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Near-Infrared Imaging Market Outlook, FY2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Devices
      • 4.2.1.1.1. Near-infrared Fluorescence Imaging Systems
      • 4.2.1.1.2. Near-infrared Fluorescence and Bioluminescence Imaging Systems
    • 4.2.1.2. Reagents
      • 4.2.1.2.1. Indocyanine Green (ICG)
      • 4.2.1.2.2. Other Reagents
  • 4.2.2. By Application
    • 4.2.2.1. Preclinical Imaging
    • 4.2.2.2. Cardiovascular Surgeries
    • 4.2.2.3. Gastrointestinal Surgeries
    • 4.2.2.4. Cancer Surgeries
    • 4.2.2.5. Plastic/Reconstructive Surgeries
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals and Clinics
    • 4.2.3.2. Pharmaceutical and Biotechnology Companies
    • 4.2.3.3. Research Laboratories
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Central
    • 4.2.4.3. South
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Regulatory Approvals
• 12.2. Innovations

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Carl Zeiss Meditec AG
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 15.3.2. Shimadzu Corporation
  • 15.3.3. Stryker Corporation.
  • 15.3.4. Olympus Corporation.
  • 15.3.5. Hamamatsu Photonics K.K.
  • 15.3.6. Medtronic plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer